DRY EYE. Other disorders of lacrimal gland
Conditions
Interventions
Intervention 1: In this study, of the two eyes of the patient, one is in the control group and one is in the intervention group. In the intervention group, both artelac eye drop and estradiol eye drop
Treatment - Drugs
In this study, of the two eyes of the patient, one is in the control group and one is in the intervention group. In the intervention group, both artelac eye drop and estradiol eye drop are used.
In the control group, both artelac and pure water eye drop, as the placebo, will be used.
For decreasing bias in this RCT, this is a double-blinded randomized control trial, and neither the patients nor the examiner, are aware of the special treatment for each eye of the patients. For ever
Sponsors
Eye research center of emam khomeini ahvaz
Eligibility
Sex/Gender
Female
Age
40 Years to 80 Years
Inclusion criteria
Inclusion criteria: Inclusion Criteria : All women with dry eye syndrome after menopause referred to Emam Khomeini Hospital Exclusion Criteria: Previous usage of any type of eye drops; Previous eye surgery; Rheumatologic disease; Previous systemic Hormone Therapy
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improvement of lacrimation. Timepoint: 3 weeks , 6 weeks , 3 months. Method of measurement: Schirmer test 1 and 2. | — |
Secondary
| Measure | Time frame |
|---|---|
| Cct. Timepoint: 3 weeks , 6 weeks , 3 months. Method of measurement: pachymetry. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMandana Esfahani . MD
Ahvaz Jundishapour University of Medical Sciences
Outcome results
None listed